While all of the institutions have not as yet reported their exposure to the company as of 9/30/15, most have. For the first time, we could see institutional exposure experience a quarterly decline. Also, for the first time, JP Morgan Chase reported a decrease in exposure of 869 thousand shares. They have always been one of the company's strongest supporters. Is it Novadaq or growing concern related to overall market conditions. I believe it is a little of each.
Yes, the company is making progress across a broad front as evidenced by the comments made at yesterday's meeting. Thanks again AG and Pezel for attending and providing your insights. However, it seems clear that concerns related to business development remain high given the size of the sales force. We need the kind of quarterly revenues that AG believes are possible this quarter.
It will be interesting to see what if any verification you can get to help substantiate the possibility of the 4th quarter generating $24 million in revenues. The one question i have related to your analysis relates to their comment during the recent CC that the company had already installed 20 devices for the quarter. We have inadequate history upon which we can project that the number of installations occurring during the first 28 days of the quarter will result in X number of installations for the entire quarter. It was an excellent start of the quarter for sure. Looking forward to your comments and those of Pezel.
I would have enjoyed meeting you and Pezel as well. This message board is not very active and is primarily visited by us die hard Novadaq investors. Your last message was very cyrptic to say the least. lol. Why not share with us now those comments you considered to be very encouraging that could result in a "whopper" of a Q4 surprise. Might be worthwhile for all of us to examine those comments before you attend the Investor Day conference.
In the middle of July, the stock hit $3.50 but backed off as the RSI hit 70, which is an over bought signal. In the middle of September the exact same thing happened. Here in early November we are again having trouble breaking through $3.50 as again the RSI is at 70. At the same time, a resistance chart doesn't show much resistance above the $3.50 level.
Over the next two weeks the company is scheduled to make the following presentations:
1) 11/16 - Analyst & Investor Day
2) 11/18 - Stifel Healthcare
3) 11/19 -` Canaccord Genuity
The 3rd quarter CC was upbeat related to revenue expectations for the 4th quarter. While no numbers were mentioned and no indication was given related to meeting 2015 annual revenue forecast, the company, in response to a question, did indicate that they expected the growth in the 4th quarter over the 3rd quarter would return to historical patterns.
it will be interesting to see if 2015 revenue forecast are discussed in the above 3 events and whether or not the same positive disposition is expressed as was the case in the recent CC. I received an invitation to attend the Investor day conference but have a medical conflict. I look forward to the postings of the folks who have attended in the past.
One last point. When the company presents at Canaccord, we will be 7 weeks into the 12 weeks of the 4th quarter. At that point, given lead times inherent in the nature of the business, they will have a pretty clear insight into how the quarter will turn out. Obviously, they cannot say anything specific, so we're going to have rely on reading the tea leaves of comments made ad how enthusiastically those comments are made. What else is new. lol